Lu Li

发表

Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center

Jun Zheng, Wenjie Zheng, Zhimian Wang, 2021, Therapeutic advances in chronic disease.

The Clinical Features, Risk Factors, and Outcome of Aneurysmal Lesions in Behcet's Disease

Yining Wang, Wenjie Zheng, Luxi Sun, 2019, Journal of immunology research.

Aberrant monocyte subsets in patients with Behçet's disease.

Xin Yu, Fengchun Zhang, Hua Chen, 2021, Clinical immunology.

Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet’s disease

Xin Yu, Fengchun Zhang, Hua Chen, 2022, Proceedings of the National Academy of Sciences of the United States of America.

A pilot study of tofacitinib for refractory Behçet’s syndrome

Fengchun Zhang, Wenjie Zheng, Luxi Sun, 2020, Annals of the Rheumatic Diseases.

Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet’s Disease

Xin Yu, Fengchun Zhang, Hua Chen, 2021, Frontiers in Immunology.

Transcriptional analysis of neutrophils from patients with Behçet's disease reveals activation and chemotaxis of neutrophils.

Xin Yu, Hua Chen, Wenjie Zheng, 2022, Clinical immunology.

Clinical manifestations of Behçet’s disease in a large cohort of Chinese patients: gender- and age-related differences

Wenjie Zheng, Jinjing Liu, Lu Li, 2020, Clinical Rheumatology.

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series

Zhimian Wang, Luxi Sun, Jinjing Liu, 2022, Therapeutic advances in chronic disease.

Tocilizumab in the treatment of severe and/or refractory vasculo-Behçet's disease: a single-centre experience in China.

Xin Yu, Yining Wang, Hua Chen, 2018, Rheumatology.

Aberrant FcγRIIb and FcγRIII expression on monocytes from patients with Behçet's disease.

Xin Yu, Fengchun Zhang, Xuan Zhang, 2020, Clinical immunology.